2014
Insight and attitudes towards medication among inpatients with chronic schizophrenia in the US and China
Mohamed S, Rosenheck R, He H, Yuping N. Insight and attitudes towards medication among inpatients with chronic schizophrenia in the US and China. Social Psychiatry And Psychiatric Epidemiology 2014, 49: 1063-1070. PMID: 24549835, DOI: 10.1007/s00127-014-0824-1.Peer-Reviewed Original ResearchConceptsDrug Attitude InventorySchizophrenia symptomsPsychiatric hospitalOverall severityMeasures of insightGuangzhou Psychiatric HospitalTime of admissionBenefits of medicationsLarge psychiatric hospitalNegative Syndrome ScaleTreatment Attitudes QuestionnaireSymptoms of schizophreniaAcceptance of medicationHospitalized patientsAntipsychotic treatmentDAI scoresChronic schizophreniaMedicationsAnalysis of covarianceSyndrome ScaleMental illnessBivariate analysisSymptomsLarger studySchizophrenia
2013
Adding antidepressants to antipsychotics for treatment of subsyndromal depressive symptoms in schizophrenia: Impact on positive and negative symptoms
Vahia IV, Lanouette NM, Golshan S, Fellows I, Mohamed S, Kasckow JW, Zisook S. Adding antidepressants to antipsychotics for treatment of subsyndromal depressive symptoms in schizophrenia: Impact on positive and negative symptoms. Indian Journal Of Psychiatry 2013, 55: 144-148. PMID: 23825848, PMCID: PMC3696237, DOI: 10.4103/0019-5545.111452.Peer-Reviewed Original ResearchAnti-psychotic medicationSubsyndromal depressionNegative symptomsDepressive symptomsSchizoaffective disorderNegative Syndrome Scale (PANSS) scoresPANSS negative symptom scoreFlexible-dose treatmentSchizophrenia/schizoaffective disorderSubsyndromal depressive symptomsPANSS positive scoreNegative symptom scoresAntidepressant augmentationPlacebo augmentationSymptom scoresCitalopram groupStudy criteriaTreatment groupsAnalysis of covarianceScale scoreSymptomsCitalopramSchizophreniaPositive scoreMedications
2006
Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia
Mohamed S, Bondi MW, Kasckow JW, Golshan S, Jeste DV. Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia. International Journal Of Geriatric Psychiatry 2006, 21: 711-718. PMID: 16862606, DOI: 10.1002/gps.1528.Peer-Reviewed Original ResearchConceptsAlcohol abuse/dependenceAbuse/dependenceSchizophrenia patientsCognitive statusAlcohol useHigher cognitive functionsWorse cognitive scoresQuality of lifeYounger schizophrenia patientsOlder groupNeuropsychological functioningNeurocognitive functioningCognitive functionCognitive scoresWorse cognitionIntervention researchCognitionDiagnosis of schizophreniaSame-aged groupPsychopathologic assessmentSchizoaffective disorderSymptom profilesLater lifeAge groupsSchizophrenia
2005
Stability of Cognitive Performance in Older Patients With Schizophrenia: An 8-Week Test-Retest Study
Harvey PD, Palmer BW, Heaton RK, Mohamed S, Kennedy J, Brickman A. Stability of Cognitive Performance in Older Patients With Schizophrenia: An 8-Week Test-Retest Study. American Journal Of Psychiatry 2005, 162: 110-117. PMID: 15625208, DOI: 10.1176/appi.ajp.162.1.110.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsAgedAlgorithmsAmbulatory CareAntipsychotic AgentsCognition DisordersFemaleFollow-Up StudiesHumansMaleMiddle AgedNeuropsychological TestsPsychiatric Status Rating ScalesPsychometricsPsychomotor PerformanceReproducibility of ResultsSchizophreniaSchizophrenic PsychologySeverity of Illness IndexConceptsCognitive measuresCognitive performancePractice effectsComprehensive neuropsychological test batteryTest scoresReliable change index methodCognitive-enhancing medicationsNeuropsychological test batteryCognitive test scoresSignificant test-retest correlationsModest cognitive improvementTest-retest correlationsTest-retest performanceCognitive improvementTest batterySecond-generation antipsychotic medicationsTest-retest errorSchizophrenia patientsRetest studyAntipsychotic medicationAlternate formsConventional antipsychotic medicationsSchizophreniaSpurious improvementPrior studies
1999
Insight in Schizophrenia: Its Relationship to Measures of Executive Functions
MOHAMED S, FLEMING S, PENN D, SPAULDING W. Insight in Schizophrenia: Its Relationship to Measures of Executive Functions. The Journal Of Nervous And Mental Disease 1999, 187: 525-531. PMID: 10496507, DOI: 10.1097/00005053-199909000-00001.Peer-Reviewed Original ResearchConceptsExecutive functionAspects of executiveNegative symptomsChronic schizophreniaExecutive functioningNeuropsychological processesGeneral intelligenceNeuropsychological functionAssess UnawarenessGroup of individualsPoor insightMental disordersSchizophreniaUnawarenessSpecific symptomsMisattributionIndividualsPerformance measuresSymptomsMeasuresFunctioningLack of awarenessMotivationDeficitsIntelligence